Enzymatic kinetic resolution of an intermediate alcohol of the drug Tegoprazan using lipase from Thermomyces lanuginosus

References

• Antonio CM, Javier L, Ursula TP, Juan MH, María DQ, Antoni MC, Eduardo RC. 2023. Risk factors for functional dyspepsia, erosive and non-erosive gastroesophageal reflux disease: a cross-sectional study. Gastroenterologíay Hepatologí. 46(7):542–552. doi: 10.1016/j.gastrohep.2022.12.005.
   PubMed Web of Science ®Google Scholar
• Banoth L, Banerjee UC. 2017. New chemical and chemo-enzymatic synthesis of (RS)-, (R)-, and (S)-esmolol. Arab J Chem. 10:S3603–S3613. doi: 10.1016/j.arabjc.2014.03.011.
   Web of Science ®Google Scholar
• Banoth L, Chandarrao B, Pujala B, Chakraborti AK, Banerjee UC. 2013. Efficient chemoenzymatic synthesis of (RS)-(R)-, and (S)-bunitrolol. Synthesis. 46(4):479–488. doi: 10.1055/s-0033-1340465.
   Web of Science ®Google Scholar
• Banoth L, Narayan TK, Banerjee UC. 2012. New chemical and chemo-enzymatic routes for the synthesis of (RS)- and (S)-enciprazine. Tetrahedron: Asymmetry. 23(17):1272–1278. doi: 10.1016/j.tetasy.2012.08.002.
   Google Scholar
• Banoth L, Narayan TK, Pujala B, Chakraborti AK, Banerjee UC. 2012. New chemo-enzymatic synthesis of (R)-1-chloro-3-(piperidin-1-yl)propan-2-ol. Tetrahedron: Asymmetry. 23(22–23):1564–1570. doi: 10.1016/j.tetasy.2012.10.008.
   Google Scholar
• Banoth L, Singh M, Tekewe A, Banerjee U. 2009. Increased enantioselectivity of lipase in the transesterification of DL-(±)-3-phenyllactic acid in ionic liquids. Biocatal Biotransform. 27(4):263–270. doi: 10.1080/10242420903049903.
   Web of Science ®Google Scholar
• Bitterling H, Schäfer U, Krammer G, Meier L, Brückner SI, Hartmann B, Ongouta J, Carle R, Steingass CB. 2020. Investigations into the natural occurrence of phenylethyl acetate (styrallyl acetate). J Agric Food Chem. 68(32):8613–8620. doi: 10.1021/acs.jafc.0c02758.
   PubMed Web of Science ®Google Scholar
• Boros Z, Falus P, Márkus M, Weiser D, Oláh M, Hornyánszky G, Nagy J, Poppe L. 2013. How the mode of Candida Antarctica lipase B immobilization affects the continuous-flow kinetic resolution of racemic amines at various temperatures. J Mol Catal B: Enzymatic. 85–86:119–125. doi: 10.1016/j.molcatb.2012.09.004.
   Google Scholar
• Buhr W, Zimmermann PJ, Chiesa V, Palmer A, Brehm C, Grundler C, Senn-Bilfinger J, Simon WA, Postius S, Kromer W, inventors; Atlana Pharma Ag, assignee. 2004 jul 01. 4-substituted benzimidazoles and their use as inhibitors of gastric secretion. World Intellectual Property Organization patent WO 2004054984.
   Google Scholar
• Chattopadhyay K, Mazumdar S. 2000. Structural and conformational stability of horseradish peroxidase: effect of temperature and pH. Biochem. 39(1):263–270. doi: 10.1021/bi990729o.
   PubMed Web of Science ®Google Scholar
• Chen CS, Fujimoto Y, Girdaukas G, Sih CJ. 1982. Quantitative analyses of biochemical kinetic resolutions of enantiomers. J Am Chem Soc. 104(25):7294–7299. doi: 10.1021/ja00389a064.
   Web of Science ®Google Scholar
• Dwivedee BP, Ghosh S, Bhaumik J, Banoth L, Banerjee UC. 2015. Lipase-catalyzed green synthesis of enantiopure atenolol. RSC Adv. 5(21):15850–15860. doi: 10.1039/C4RA16365F.
   Web of Science ®Google Scholar
• Fulin L, Ying L, Lei Z, Hua Z, Rong Z, Yue Q, Xianhua P, inventors; Shanghai Baishi Biotechnology Co ltd Shanghai Ruikang Biotechnology R & D Co ltd, assignee. 2022 Sep 09. Preparation method of (R)-5,7-difluorochroman-4-ol. Chinese Patent CN 115029397A.
   Google Scholar
• Haiping Z, Shangyan Y, inventors; Changzhou Vocational Institute of Engineering, assignee. 2022 Aug 16. Preparation method of chiral chromanol of tegorazalol intermediate. Chinese patent CN 114907303A.
   Google Scholar
• Hanazawa T, Koike H, inventors; Pfizer Japan Inc, assignee. 2007 Jun 28. Chromane substituted benzimidazoles and their use as acid pump inhibitors. World Intellectual Property Organization patent WO 2007072146.
   Google Scholar
• Hongyi Z, Dongfeng Z, Gang L, Haihong H, inventors; Institute of Materia Medica of CAMS, assignee. 2021 May 28. Preparation method of Tegolrazan. Chinese patent CN 112851646A.
   Google Scholar
• Inatomi N, Matsukawa J, Sakurai Y, Otake K. 2016. Potassium-competitive acid blockers: advanced therapeutic option for acid-related diseases. Pharm & Thera. 168:12–22. doi: 10.1016/j.pharmthera.2016.08.001.
   PubMed Web of Science ®Google Scholar
• Koike H, Hanase T, inventors; Raqualia Pharma Inc, assignee. 2011 Jun 08. Chromane substituted benzimidazoles and their use as acid pump inhibitors. Chinese patent CN 101341149B.
   Google Scholar
• Lowe RC. 2006. Medical management of gastroesophageal reflux disease. GI Motilityonline. doi: 10.1038/gimo54.
   Google Scholar
• Nayak KS, Reddy PR, Rosangzuala K, Anand P, Manjula N, Sandip PV, Banoth L. 2023. Lipase catalyzed chemo-enzymatic synthesis of propranolol: a newer enzymatic approach. J Indian Chem Soc. 100(7):101037. doi: 10.1016/j.jics.2023.101037.
   Web of Science ®Google Scholar
• Patlolla RR, Deepthi P, Raveena G, Rosangzuala K, Tejaswini S, Prakasham RS, Banoth L. 2024. Lipase mediated new chemo-enzymatic synthesis of (RS)-,(R)-, and (S)-bunolol. Chirality. 36(1):e23627. doi: 10.1002/chir.23627.
   PubMedGoogle Scholar
• Rakels JLL, Straathof AJJ, Heijnen JJ. 1993. A simple method to determine the enantiomeric ratio in enantioselective biocatalysis. Enzyme Microb Technol. 15(12):1051–1056. doi: 10.1016/0141-0229(93)90053-5.
   PubMed Web of Science ®Google Scholar
• Reetz MT, Eipper A, Tielmann P, Mynott R. 2002. A practical NMR-based high-throughput assay for screening enantioselective catalysts and biocatalysts. Adv Synth Catal. 344(9):1008–1016. doi: 10.1002/1615-4169(200210)344:9%3C1008.
   Web of Science ®Google Scholar
• Romero EO, Saucedo AT, Hernández-Meléndez JR, Yang D, Chakrabarty S, Narayan AR. 2023. Enabling broader adoption of biocatalysis in organic chemistry. JACS Au. 3(8):2073–2085. doi: 10.1021/jacsau.3c00263.
   PubMedGoogle Scholar
• Saptarshi G, Bhaumik J, Banoth L, Banesh S, Banerjee UC. 2016. Chemo-enzymatic Route for the Synthesis of (S)-Moprolol, a Potential β-Blocker. Chirality. 28(4):313–318. doi: 10.1002/chir.22574.
   PubMed Web of Science ®Google Scholar
• Seon KE, Hyeon KD, Hong KJ, Ju KY, Seong L, Do CG, Pyeong HS, Yun LJ, inventors; CJ Healthcare Co., Ltd., assignee. 2017 Aug 17. New method for preparation of chiral chromanol derivatives. Korean patent KR 101769204B1.
   Google Scholar
• Sheldon RA, Woodley JM. 2018. Role of biocatalysis in sustainable chemistry. Chem Rev. 118(2):801–838. doi: 10.1021/acs.chemrev.7b00203.
   PubMed Web of Science ®Google Scholar
• Takahashi N, Take Y. 2018. Tegoprazan, a novel potassium-competitive acid blocker to control gastric acid secretion and motility. J Pharmacol Exp Ther. 364(2):275–286. doi: 10.1124/jpet.117.244202.
   PubMed Web of Science ®Google Scholar
• Takao T, Okada H, Kawahara Y, Takenaka R, Nasu J, Ishioka H, Fujiwara A, Yoshinaga F, Yamamoto K. 2011. Proton pump inhibitor step-down therapy for GERD: a multi-center study in Japan. World J. Gastroenterol. 17(11):1480–1487. doi: 10.3748/wjg.v17.i11.1480.
   PubMed Web of Science ®Google Scholar
• Takeshi H, Hiroki K,inventors; Raqualia Pharma Inc, assignee. 2010 Jun 21. Chromane substituted benzimidazole derivatives. United States patent US 2007/0142448 A.
   Google Scholar
• Yoshikazu K, Ishimura N, Ishihara S. 2018. Advantages and disadvantages of long-term proton pump inhibitor use. J Neurogastroenterol Motil. 24(2):182–196. doi: 10.5056/jnm18001.
   PubMed Web of Science ®Google Scholar
• Zhuotong X, Yong F, Lu Y, Yang W, Teng L, Sen Z, inventors; Xi’an Pure & True New Materials Co ltd, assignee. 2021 Oct 22. Synthesis method of Tegolazan. Chinese patent CN 113527272A.
   Google Scholar
• Zieniuk B, Fabiszewska A, Białecka-Florjańczyk E. 2020. Screening of solvents for favoring hydrolytic activity of Candida antarctica Lipase B. Bioprocess Biosyst Eng. 43(4):605–613. doi: 10.1007/s00449-019-02252-0.
   PubMed Web of Science ®Google Scholar